UNSPSC 51334601: Lithium carbonate/sodium chloride

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN750. This VA Drug Class (CN750) classifies this compound as belonging to the group LITHIUM SALTS.

UNSPSC 51334601 Lithium carbonate/sodium chloride is a Commodity code that in recent state and local practice covers pharmaceutical products and medical supplies, though the recent opportunities posted under it show little connection to the code's nominal chemical scope. State and local governments are soliciting naloxone and drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products, and direct-to-manufacturer prescription program capabilities through this code. Issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple state and local participants across member jurisdictions including Oregon). The work involves competitive procurement of pharmaceutical inventory, medical countermeasures, and pharmacy benefit program infrastructure rather than chemical commodities.

Recent activity spans Florida, Texas, and the upper Midwest. Seminole County, Florida posted IFB 60459723LAS in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, response due July 26, 2023. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 seeking vendor capability information for a direct-to-manufacturer prescription program as an early-stage market intelligence tool before formal procurement. The Minnesota Department of Administration's Office of State Procurement, administering the MMCAP cooperative purchasing vehicle, posted RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, proposals due March 26, 2026, with contract effectiveness July 1, 2026. All three opportunities require vendors to demonstrate manufacturing compliance (cGMP, DSCSA), maintain adequate insurance, and support electronic ordering systems; the code itself does not carry explicit set-aside or disadvantaged-enterprise designations in the posted solicitations.